Boston Scientific(US:BSX) ZACKSยท2024-10-10 23:20Company Performance - Boston Scientific (BSX) closed at $86.20, down 0.58% from the previous trading session, underperforming the S&P 500 which lost 0.21% [1] - Over the past month, BSX shares gained 4.53%, outperforming the Medical sector's decline of 3.28% but lagging behind the S&P 500's increase of 5.94% [1] - The upcoming earnings report on October 23, 2024, is projected to show earnings of $0.58 per share, reflecting a year-over-year growth of 16%, with revenue expected to be $4.03 billion, indicating a 14.36% increase [1] Earnings Estimates - The full-year Zacks Consensus Estimates for BSX are earnings of $2.40 per share and revenue of $16.26 billion, representing year-over-year changes of +17.07% and +14.22%, respectively [2] - Recent changes to analyst estimates suggest a favorable outlook on the company's business health and profitability [2] Valuation Metrics - Boston Scientific has a Zacks Rank of 2 (Buy), with the Zacks Consensus EPS estimate increasing by 0.07% in the past month [3] - The company has a Forward P/E ratio of 36.12, which is a premium compared to the industry's average Forward P/E of 24.88 [3] - BSX's PEG ratio stands at 2.87, compared to the Medical - Products industry's average PEG ratio of 1.92 [3] Industry Overview - The Medical - Products industry is part of the Medical sector and holds a Zacks Industry Rank of 69, placing it in the top 28% of over 250 industries [4] - The Zacks Industry Rank indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [4]